These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1651 related articles for article (PubMed ID: 10964770)

  • 21. HIV-1 Vpr transactivates LTR-directed expression through sequences present within -278 to -176 and increases virus replication in vitro.
    Vanitharani R; Mahalingam S; Rafaeli Y; Singh SP; Srinivasan A; Weiner DB; Ayyavoo V
    Virology; 2001 Oct; 289(2):334-42. PubMed ID: 11689055
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influenza virus activates human immunodeficiency virus type-1 gene expression in human CD4-expressing T cells through an NF-kappaB-dependent pathway.
    Sun J; Bergeron M; Barbeau B; Boivin G; Tremblay MJ
    Clin Immunol; 2005 Feb; 114(2):190-8. PubMed ID: 15639653
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reactive oxygen species activate HIV long terminal repeat via post-translational control of NF-kappaB.
    Pyo CW; Yang YL; Yoo NK; Choi SY
    Biochem Biophys Res Commun; 2008 Nov; 376(1):180-5. PubMed ID: 18765232
    [TBL] [Abstract][Full Text] [Related]  

  • 24. H. saimiri tyrosine-kinase interacting protein inhibits Tat function: a prototypic strategy for restricting HIV-1-induced cytopathic effects in immune cells.
    Raymond AD; Hasham M; Tsygankov AY; Henderson EE
    Virology; 2006 Sep; 352(2):253-67. PubMed ID: 16780912
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mechanisms of transcriptional transactivation and restriction of human immunodeficiency virus type I replication in an astrocytic glial cell.
    Niikura M; Dornadula G; Zhang H; Mukhtar M; Lingxun D; Khalili K; Bagasra O; Pomerantz RJ
    Oncogene; 1996 Jul; 13(2):313-22. PubMed ID: 8710370
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mutational analysis of the HIV-1 LTR as a promoter of negative sense transcription.
    Bentley K; Deacon N; Sonza S; Zeichner S; Churchill M
    Arch Virol; 2004 Dec; 149(12):2277-94. PubMed ID: 15338321
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Structure-functional analysis of human immunodeficiency virus type 1 (HIV-1) Vpr: role of leucine residues on Vpr-mediated transactivation and virus replication.
    Thotala D; Schafer EA; Tungaturthi PK; Majumder B; Janket ML; Wagner M; Srinivasan A; Watkins S; Ayyavoo V
    Virology; 2004 Oct; 328(1):89-100. PubMed ID: 15380361
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of the signal transduction pathway leading to human immunodeficiency virus-1-induced interferon regulatory factor-1 upregulation.
    Sgarbanti M; Marsili G; Remoli AL; Ridolfi B; Stellacci E; Borsetti A; Ensoli B; Battistini A
    Ann N Y Acad Sci; 2004 Dec; 1030():187-95. PubMed ID: 15659797
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tat-dependent repression of human immunodeficiency virus type 1 long terminal repeat promoter activity by fusion of cellular transcription factors.
    Zhao C; Chen Y; Park J; Kim JB; Tang H
    Biochem Biophys Res Commun; 2004 Sep; 322(2):614-22. PubMed ID: 15325274
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A CNS-enriched factor that binds to NF-kappa B and is required for interaction with HIV-1 tat.
    Taylor JP; Pomerantz RJ; Oakes JW; Khalili K; Amini S
    Oncogene; 1995 Jan; 10(2):395-400. PubMed ID: 7838536
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Determination of the minimal amount of Tat activity required for human immunodeficiency virus type 1 replication.
    Verhoef K; Koper M; Berkhout B
    Virology; 1997 Oct; 237(2):228-36. PubMed ID: 9356335
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of human cytomegalovirus target sequences in the human immunodeficiency virus long terminal repeat. Potential role of IE2-86 binding to sequences between -120 and -20 in promoter transactivation.
    Yurochko AD; Huong SM; Huang ES
    J Hum Virol; 1999; 2(2):81-90. PubMed ID: 10225210
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differences in transcriptional enhancers of HIV-1 and HIV-2. Response to T cell activation signals.
    Tong-Starksen SE; Welsh TM; Peterlin BM
    J Immunol; 1990 Dec; 145(12):4348-54. PubMed ID: 2258623
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transactivation is a conserved function among primate lentivirus Vpr proteins but is not shared by Vpx.
    Philippon V; Matsuda Z; Essex M
    J Hum Virol; 1999; 2(3):167-74. PubMed ID: 10413368
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Regulation of the human immunodeficiency virus type 1 long terminal repeat: interactions of thyroid hormone receptor with retinoid-X receptor, nuclear factor kappa B, Sp1, and Tat.
    Desai-Yajnik V; Samuels HH
    Trans Assoc Am Physicians; 1993; 106():13-32. PubMed ID: 8036737
    [No Abstract]   [Full Text] [Related]  

  • 36. Role of glucocorticoid receptor binding sites in the human immunodeficiency virus type 1 long terminal repeat in steroid-mediated suppression of HIV gene expression.
    Mitra D; Sikder SK; Laurence J
    Virology; 1995 Dec; 214(2):512-21. PubMed ID: 8553553
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Derivation of infectious HIV-1 molecular clones with LTR mutations: sensitivity to the CD8+ cell noncytotoxic anti-HIV response.
    Bonneau KR; Ng S; Foster H; Choi KB; Berkhout B; Rabson A; Mackewicz CE; Levy JA
    Virology; 2008 Mar; 373(1):30-8. PubMed ID: 18086484
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The most frequent naturally occurring length polymorphism in the HIV-1 LTR has little effect on proviral transcription and viral replication.
    Hiebenthal-Millow K; Kirchhoff F
    Virology; 2002 Jan; 292(1):169-75. PubMed ID: 11878920
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Infection of human brain cells by HIV-1: restricted virus production in chronically infected human glial cell lines.
    Brack-Werner R; Kleinschmidt A; Ludvigsen A; Mellert W; Neumann M; Herrmann R; Khim MC; Burny A; Müller-Lantzsch N; Stavrou D
    AIDS; 1992 Mar; 6(3):273-85. PubMed ID: 1373627
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transcriptional activation of minimal HIV-1 promoter by ORF-1 protein expressed from the SalI-L fragment of human herpesvirus 6.
    Kashanchi F; Thompson J; Sadaie MR; Doniger J; Duvall J; Brady JN; Rosenthal LJ
    Virology; 1994 May; 201(1):95-106. PubMed ID: 8178493
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 83.